NKTR
Dr. Mary Tagliaferri
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Mary Tagliaferri
Dr. Mary Tagliaferri has spoken on 2 earnings calls across 1 company, most recently for Nektar Therapeutics on August 13, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Nektar Therapeutics (NKTR)
Source not stated
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Nektar Therapeutics
Other people whose current roles at this company are on record from its filings.
- Howard Robin CEO
- Linda Rubinstein CFO
- Sandra Gardiner CFO
- Jillian Thomsen Chief Accounting Officer
- Diana M. Brainard, M.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.